Business Description
![RAPT Therapeutics Inc RAPT Therapeutics Inc logo](https://static.gurufocus.com/logos/0C0000BNYF.png?14)
RAPT Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US75382E1091
Share Class Description:
FRA:0RA: Ordinary SharesDescription
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 20.05 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.05 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -15 | |||||
3-Year EPS without NRI Growth Rate | -11.7 | |||||
3-Year FCF Growth Rate | -14.8 | |||||
3-Year Book Growth Rate | 0.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 14.26 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.21 | |||||
9-Day RSI | 35.91 | |||||
14-Day RSI | 35.73 | |||||
6-1 Month Momentum % | -65.92 | |||||
12-1 Month Momentum % | -84.26 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.14 | |||||
Quick Ratio | 8.14 | |||||
Cash Ratio | 7.76 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.6 | |||||
Shareholder Yield % | -8.89 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -79.28 | |||||
ROA % | -68.68 | |||||
ROIC % | -728.22 | |||||
ROC (Joel Greenblatt) % | -1680.97 | |||||
ROCE % | -82.5 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.74 | |||||
Price-to-Tangible-Book | 0.74 | |||||
EV-to-EBIT | 0.22 | |||||
EV-to-Forward-EBIT | -0.04 | |||||
EV-to-EBITDA | 0.22 | |||||
EV-to-Forward-EBITDA | -0.04 | |||||
EV-to-Forward-Revenue | 242.61 | |||||
EV-to-FCF | 0.26 | |||||
Price-to-Net-Current-Asset-Value | 0.79 | |||||
Price-to-Net-Cash | 0.84 | |||||
Earnings Yield (Greenblatt) % | 454.55 | |||||
FCF Yield % | -129.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
RAPT Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -2.898 | ||
Beta | 0.32 | ||
Volatility % | 147.83 | ||
14-Day RSI | 35.73 | ||
14-Day ATR (€) | 0.126362 | ||
20-Day SMA (€) | 2.367 | ||
12-1 Month Momentum % | -84.26 | ||
52-Week Range (€) | 1.9 - 24.2 | ||
Shares Outstanding (Mil) | 34.9 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
RAPT Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
RAPT Therapeutics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
RAPT Therapeutics Inc Frequently Asked Questions
What is RAPT Therapeutics Inc(FRA:0RA)'s stock price today?
The current price of FRA:0RA is €2.04. The 52 week high of FRA:0RA is €24.20 and 52 week low is €1.90.
When is next earnings date of RAPT Therapeutics Inc(FRA:0RA)?
The next earnings date of RAPT Therapeutics Inc(FRA:0RA) is 2024-11-13 Est..
Does RAPT Therapeutics Inc(FRA:0RA) pay dividends? If so, how much?
RAPT Therapeutics Inc(FRA:0RA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |